1[1]van der Velden VH,Hochhaus A,Cazzaniga G,et al.Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR:principles,approaches,and laboratory aspects[J].Leukemia,2003,17(6):1013-1034.
3[3]Szczepanski T,Flohr T,van der Velden VH,et al.Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia[J].Best Pract Res Clin Haematol,2002,15(1):37-57.
4[4]Li A,Zhou J,Zuckerman D,et al.Sequence analysis of clonal immunoglobulin and T-cell receptor gene rear rangements in children with acute lymphoblastic leukemia at diagnosis and at relapse:implications for pathogenesis and for the clinical utility of PCR-based methods of minimal residual disease detection[J].Blood,2003,102(13):4520-4526.
5[5]Slovak ML,Kopecky KJ,Cassileth PA,et al.Karyotypicanalysis predicts outcome of preremission and postremis sion therapy in adult acute myeloid leukemia:a South west Oncology Group/Eastern Cooperative Oncology Group Study[J].Blood,2000,96(13):4075-4083.
6[8]Kyoda K,Nakamura S,Matano S,et al.Prognostic signif icance of immunoglobulin heavy chain gene rearrange ment in patients with acute myelogenous leukemia[J].Leukemia,1997,11(6):803-806.
